The ATM kinase inhibitor KU-55933 provides neuroprotection against hydrogen peroxide-induced cell damage via a γH2AX/p-p53/caspase-3-independent mechanism: Inhibition of calpain and cathepsin D

Int J Biochem Cell Biol. 2017 Jun:87:38-53. doi: 10.1016/j.biocel.2017.03.015. Epub 2017 Mar 21.

Abstract

The role of the kinase ataxia-telangiectasia mutated (ATM), a well-known protein engaged in DNA damage repair, in the regulation of neuronal responses to oxidative stress remains unexplored. Thus, the neuroprotective efficacy of KU-55933, a potent inhibitor of ATM, against cell damage evoked by oxidative stress (hydrogen peroxide, H2O2) has been studied in human neuroblastoma SH-SY5Y cells and compared with the efficacy of this agent in models of doxorubicin (Dox)- and staurosporine (St)-evoked cell death. KU-55933 inhibited the cell death induced by H2O2 or Dox but not by St in undifferentiated (UN-) and retinoic acid-differentiated (RA)-SH-SY5Y cells, with a more pronounced effect in the latter cell phenotype. Furthermore, this ATM inhibitor attenuated the Dox- but not H2O2-induced caspase-3 activity in both UN- and RA-SH-SY5Y cells. Although KU-55933 inhibited the H2O2- and Dox-induced activation of ATM, it attenuated the toxin-induced phosphorylation of the proteins H2AX and p53 only in the latter model of cell damage. Moreover, the ATM inhibitor prevented the H2O2-evoked increases in calpain and cathepsin D activity and attenuated cell damage to a similar degree as inhibitors of calpain (MDL28170) and cathepsin D (pepstatin A). Finally, we confirmed the neuroprotective potential of KU-55933 against the H2O2- and Dox-evoked cell damage in primary mouse cerebellar granule cells and in the mouse hippocampal HT-22 cell line. Altogether, our results extend the neuroprotective portfolio of KU-55933 to a model of oxidative stress, with this effect not involving inhibition of the γH2AX/p-p53/caspase-3 pathway and instead associated with the attenuation of calpain and cathepsin D activity.

Keywords: Cerebellar granule cells; Doxorubicin; MDL28170; Pepstatin A; SH-SY5Y cells; Staurosporine.

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Ataxia Telangiectasia Mutated Proteins / antagonists & inhibitors*
  • Calpain / antagonists & inhibitors*
  • Caspase 3 / metabolism
  • Cathepsin D / antagonists & inhibitors*
  • Cell Death / drug effects
  • Cell Differentiation / drug effects
  • Cell Line, Tumor
  • Dose-Response Relationship, Drug
  • Doxorubicin / pharmacology
  • Enzyme Activation / drug effects
  • Histones / metabolism
  • Humans
  • Hydrogen Peroxide / pharmacology*
  • Mice
  • Morpholines / pharmacology*
  • Neurons / cytology
  • Neurons / drug effects
  • Neurons / metabolism
  • Neuroprotective Agents / pharmacology*
  • Phosphoproteins / metabolism
  • Protein Kinase Inhibitors / pharmacology*
  • Pyrones / pharmacology*
  • Rats
  • Staurosporine / pharmacology
  • Tumor Suppressor Protein p53 / metabolism

Substances

  • 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one
  • H2AX protein, human
  • Histones
  • Morpholines
  • Neuroprotective Agents
  • Phosphoproteins
  • Protein Kinase Inhibitors
  • Pyrones
  • Tumor Suppressor Protein p53
  • Doxorubicin
  • Hydrogen Peroxide
  • Ataxia Telangiectasia Mutated Proteins
  • Calpain
  • Caspase 3
  • Cathepsin D
  • Staurosporine